Aridis Pharmaceuticals Inc. · OTC:ARDS
Armistice Capital, LLC reported a 9.45% stake in Aridis Pharmaceuticals Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Armistice Capital, LLC reported a 9.45% stake in Aridis Pharmaceuticals Inc., 1,512,444 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.45%
- Shares
- 1,512,444
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.45% | 1,512,444 |
| Steven Boyd | 9.45% | 1,512,444 |
Source
Related
- Aridis Pharmaceuticals Inc.
- Armistice Capital, LLC
- Aridis Pharmaceuticals Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2025
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2025
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025